AI

What is Supervised and Unsupervised Machine Learning?
Machine learning has become vital to the modern world, turning data into real, actionable insights. In radiotherapy, there has been a continuous increase in patient-specific…
What guidelines do clinicians follow for breast contouring?
According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast…
2021 MVision AI Re-cap: The Year of GCAIS™
2021 is an innovative and  foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what…
Medron Medical Systems Inc. is Introducing MVision’s Groundbreaking Auto-Segmentation Solution to Canada
Helsinki – December 9, 2021 – MVision AI, the leading software service provider of guideline-based AI segmentation, GBAIS™, for radiotherapy treatment planning, declares a new…
Important Methods for Radiotherapy Treatment
 60-70% of cancer patients receive some type of radiation therapy. For some cancers, radiation therapy alone is an effective treatment. The purpose of radiotherapy is…
SBRT as an Effective Modality for Lung Cancer Treatment
Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a…
YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals
Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime…
MVision’s On-Premise Solutions
Since the invention of the world’s first web server in 1989, servers have shaped our society and technology today. In 2020 alone, the global server…
AQUILAB Ushers In MVision’s Innovative and Guideline-Compliant AI Segmentation Solution to France
Helsinki – 29th of September 2021 – MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB,…
New Horizons for Patients with Endometrial Cancer
September is Uterine Cancer Awareness Month. Raising awareness is very close to the MVisionaries since uterine cancer is the fourth most common cancer for women.…